By Tess Stynes Biogen Idec Inc. (BIIB) said its treatment for hemophilia B, a rare inherited disorder that impairs blood coagulation, showed...
Biogen Idec Inc.'s (BIIB) second-quarter earnings fell 1.8% on acquisition-related and other charges. The biotechnology company's adjusted profit...
Swedish investment company Investor AB (INVE-B.SK) Tuesday said net asset value per share as of June 30 rose 3.6% to SEK231 from the previous...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.